Development of Olanzapine Nano-Emulsion for Enhanced Brain Delivery
The main objective of the present research work was to design, optimize and characterize olanzapine loaded nano-emulsion for improved brain transport of the drug. Olanzapine nano-emulsion was formulated using the ultrasonication method. The formulation variables (oil and surfactant) and process variables (ultrasonication time) were optimized by Response surface methodology using the Box-Behnken statistical method. Particle size, polydispersity index (PDI) and zeta potential were measured by photon correlation spectroscopy using a Malvern zeta sizer. Morphology of emulsion droplets was examined by transmission electron microscopy (TEM). Release study was performed and drug release was estimated by HPLC method. Stability studies were performed at 4oC-25oC for a period of three months. The optimized nano-emulsion obtained showed a uniform size distribution with an average size in the range of 65.1 nm to 74.21 nm and surface charge in the range of –18.9 mv to – 25.23 mv. The Transmission electron microscopy studies on olanzapine nano-emulsion revealed a spherical morphology of globules. An average of 91.91% of drug was released from the optimized formulation over a period of 24 hours. The particle size analysis after three months showed no significant change implying that the nano-emulsion was quite stable when stored at room temperature. Stable olanzapine nano-emulsion was formulated. The novel nanoformulation was found to be a potential vehicle for delivery of olanzapine to the brain.